Overview

Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea

Status:
RECRUITING
Trial end date:
2034-12-31
Target enrollment:
Participant gender:
Summary
Very high-risk acute lymphoblastic leukemia
Phase:
PHASE2
Details
Lead Sponsor:
Hyoung Jin Kang
Collaborators:
Asan Medical Center
Pusan National University Yangsan Hospital
Samsung Medical Center
Seoul St. Mary's Hospital
Severance Hospital